DaVita Inc. provides kidney dialysis services through a network of outpatient dialysis centers in the United States.
| Revenue (TTM) | $13.84B |
| Gross Profit (TTM) | $4.49B |
| EBITDA | $2.79B |
| Operating Margin | 13.90% |
| Return on Equity | 81.00% |
| Return on Assets | 7.50% |
| Revenue/Share (TTM) | $194.22 |
| Book Value | $-11.41 |
| Price-to-Book | 21.63 |
| Price-to-Sales (TTM) | 0.92 |
| EV/Revenue | 1.828 |
| EV/EBITDA | 9.34 |
| Quarterly Earnings Growth (YoY) | 43.50% |
| Quarterly Revenue Growth (YoY) | 6.00% |
| Shares Outstanding | $64.19M |
| Float | $34.09M |
| % Insiders | 50.55% |
| % Institutions | 52.07% |
Volatility is currently contracting